Since the introduction of the intravenous Congo red test by Bennhold (1923) , a number of writers have recorded observations on the intracutaneous injection of Congo red dye. Philpott and Freshman (1936) and Nomland (1936) observed intense and prolonged staining of cutaneous amyloid deposits in patients following the local injection of Congo red solution. Laine, Holopainen, and Makinen (1956) noted that Congo red solution injected into the apparently healthy skin of a group of rheumatoid arthritics disappeared more slowly than in control subjects. Shannon, Fessel, and Bywaters (1957) confirmed Laine's findings in a group of juvenile arthritics and observed that the delay in fading was most marked in the younger age groups. They noted that another dye, Evans' blue, failed to show this difference in fading.
No cause is known for this apparent dermal avidity for Congo red in patients with rheumatoid arthritis, but Shannon and others suggest a relationship to the increased tissue retention of intravenously injected Congo red demonstrated in these subjects by Dixon, Ramcharan, and Ropes (1955) . If this were so, then the skin of rheumatoid patients with secondary amyloidosis might be expected to show this delay in fading rate, perhaps to a more marked degree.
The purpose of this paper is to report a study of the fading rate of intracutaneously injected Congo red in a group of mainly adult patients with rheumatoid arthritis and to compare these with a small group of patients with amyloidosis. The results are compared with those in a control group.
Methods
The method was similar to that used by Laine and others (1956) The control group of subjects included healthy members of the staff, and other in-patients with diseases other than rheumatoid arthritis (e.g. hypertensive and ischaemic heart disease, and gastro-intestinal and respiratory diseases) of all age groups.
Results
The F.Rs. in both rheumatoid and non-rheumatoid subjects are shown in Table I Effects of Steroid Hortnones. As a number of these rheumatoid patients were receiving steroid hormones, the influence of these steroids was observed in a group of nine patients with rheumatoid arthritis and two with other diseases; the F.R. was determined both before and during the course of treatment with steroid hormones.
The group included subjects with both normal and abnormal F.Rs. and the dose of hormone used varied between 50 and 150 mg. cortisone and 10 and 30 mg. prednisolone daily. The mean F.R. without steroid treatment was 0 60 and with the hormone 0-55. This difference was not significant.
In another group of five patients, hydrocortisone acetate was added to the Congo red solution before injection, in a dose of approximately 10 mg./mi., i.e. I mg. in each injected dose. Once again no significant difference in F.R. was observed from that of the aqueous solution in the opposite arm.
Control Group.-The non-rheumatoid control group was composed of 96 subjects, 51 female and The fading index in the female group was 0 54 and that in the male group 0 59 (± S.E. 0 04 (S.D. 0 25)). The differences between these means and those of the rheumatoid group were not significant (p = 0 6 for males and p = 0 2 for females).
When all the results are plotted as a scatter diagram (Fig. l, opposite) of F.R. against age, the lack of correlation with age is clearly illustrated, and it is apparent that most results lie above the 0 3 level of F.R. This level was found to be two standard deviations below the total mean F.R. of the whole group, and levels at or below 0 3 are therefore considered abnormal. If the 28 patients with an F.R. of 0 3 or less are considered, a certain grouping of diagnoses is observed (Table II) .
This Table shows that the rheumatoid patients did not contribute materially to the abnormal group, except in those cases complicated by amyloidosis. In fact, only two uncomplicated adult rheumatoid arthritis patients had an F.R. of 0 3 or less. These groups will therefore be considered separately (Table Ill) .
Lupus Erythematosus.-The group included eight patients with systemic disease and one with chronic discoid disease of long duration. All showed a F.R. of 0 3 or less, and in two intense staining persisted for 9 and 7 months respectively until death. The mean F.R. in this group was0 13 (± S.E. 004 (S.D. 0 10)), a highly significant difference from the rheumatoid group and the control group as a whole (p = <0-001).
All the patients with systemic disease were receiving steroid hormones at the time of the test. At autopsy two patients had dye persisting at the injection site and frozen sections of this area showed the dye to be present as minute, possibly intracellular, particles. No staining of collagen fibres was seen. Sections stained with haematoxylin and eosin revealed no histological abnormality.
Amyloidosis.-Seven patients were tested; in five the amyloid was secondary to rheumatoid arthritis, in one to pulmonary tuberculosis, and in the other to post-operative bronchopleural fistula.
Three of the five rheumatoid subjects with amyloidosis and the two non-rheumatoid cases of amyloidosis had F.Rs. of less than 0 3.
The mean F.R. for this group was 0-24 (1 S.E. 0-08 (S.D. 0-21)), statistically different from that of the control group (p = <0 001). In all but one patient, in whom the diagnosis was confirmed at autopsy, intravenous Congo red tests were carried out. In Fig. 2 these are plotted against the F.R.; although the numbers are few there is a tendency for a high Congo red clearance to be associated with a slow rate of skin fading. In each of these patients the area of sA appeared normal, and in one histologic. tion of the injection site at autopsy fails evidence of local amyloidosis.
Jaundice.-Sixteen subjects were exam results are given in Fig. 3 and Table IV . suggests that young rheumatoid arthritics resorb Congo red at a considerably slower rate than control children in the same age group. The few young patients in this series failed to show a consistently slow F.R. In older patients we have shown no correlation between age and fading rate either in the rheumatoid arthritic group or in the control group, both of which showed similar rates of fading.
The abnormal results in the lupus, amyloid, and jaundiced patients are of interest, but the mechanism of their production is difficult to determine. No common factor could be found in the groups of patients which gave these abnormal results.
Not all the patients with abnormal F.Rs. were treated with steroids, and no significant alteration occurred when patients were treated with cortisone or its analogues.
It is possible that the reduction in skin, blood, and lymphatic flow in seriously ill patients could be responsible for the delay in resorption in some of these patients. However, only a small number of the patients with abnormal fading rates were seriously ill at the time of testing, while normal results were seen in dying patients in the control group.
Abnormalities of serum proteins are common in patients with lupus, amyloidosis, and hepatocellular jaundice. Electrophoresis of their sera frequently shows a low serum albumin level and raised gamma globulin levels. Since Congo red is transported in the blood in combination with albumin, the lowered level of serum albumin might be responsible for the decreased rate of resorption from the skin. However, since four patients with the nephrotic syndrome and low serum albumin levels had normal F.Rs., this phenomenon may be related more closely to altered tissue "plasma protein" (Humphrey, Neuberger, and Perkins, 1957) .
Clearly, further investigation is required to establish the factors producing the abnormality of fading rate in these groups of patients. Histological examination of skin from the injection site in patients with abnormal fading rates may establish accurately the site of deposition of the Congo red.
Summary
The vital staining of the skin with intracutaneously injected Congo red solution was investigated in 162 rheumatoid and non-rheumatoid subjects. No difference was found in the fading rates between adult rheumatoid arthritis patients and a control group of non-rheumatoid patients.
The activity of the rheumatoid disease did not influence the fading rate and no correlation could be found with age in either group. Abnormally slow resorption was found in each of eight subjects with lupus erythematosus and gross delay was observed in two.
Patients with amyloidosis showed a slow fading rate in the absence of histological abnormality of the skin.
Jaundice delayed resorption in a high proportion of subjects: this was most noticeable in obstructive jaundice.
No common factor could be found to account for the production of these abnormal results. DISCUSSION PROF. BYWATERS: I do not think there is much to add to this paper. There are very striking differences in patients in the rate of fading, and this is an attempt to give a quantitative assessment to the phenomenon, to try and account for the differences. We do not feel that we have got very far with this problem. The differences may possibly be due to the raised plasma globulins of these patients which are reflected in the tissue proteins, but that is merely speculation and we should be grateful for suggestions. DR Laine, Holopainen, and Makinen (1956) studied the rate of disappearance from the skin of intradermally-injected aqueous Congo red solution. They observed a slower rate of fading in subjects with rheumatoid arthritis than in a control group. Shannon, Fessel, and Bywaters (1957) , using a saline solution of Congo red, demonstrated delayed fading in juvenile rheumatoid arthritis, most marked in the younger age groups, and possibly related to the increased tissue retention of intravenously injected Congo red, demonstrated by Dixon, Ramcharan, and Ropes (1955 nor did age or sex influence the fading rate. Abnormally slow fading rates were seen in 28 subjects, of whom only six suffered from rheumatoid arthritis. Of these six, one had suspected and three had proven secondary amyloidosis. Two patients with amyloidosis secondary to other diseases had slow fading rates. Eight patients with lupus erythematosus, seven of whom had systemic disease, all showed delayed fading from apparently healthy skin. Sixteen jaundiced patients were studied and ten were found to have slow fading rates; of these, seven had obstructive jaundice. There was no correlation with serum bilirubin or alkaline phosphatase levels. Some of the subjects with rheumatoid arthritis and all of those with lupus were receiving steroid hormones at the time of testing. To exclude these hormones as a factor in the delayed fading rate, tests were carried out both before and during steroid treatment in nine patients; no significant difference was observed in the fading rates. The incorporation of hydrocortisone or bile pigments into the Congo red solution before injection similarly failed to influence the rate of fading.
No common factor could be found to explain this apparent dermal avidity for Congo red in the three groups of patients, but all three have abnormal serum proteins and perhaps abnormal tissue proteins too in consequence.
Resorption du rouge Congo injected par voie intradermique RtSUMt On 6tudia chez 162 sujets rhumatisants et nonrhumatisants la coloration vitale de la peau apres l'injection intradermique d'une solution de rouge Congo. On n'observa pas de difference entre les vitesses de discoloration chez les rhumatisants arthritiques adultes et chez les temoins non-rhumatisants.
Le degree d'activite de la maladie rhumatismale n'influenqa pas la vitesse de discoloration et on ne trouva pas de correlation avec l'age dans aucun groupe. Une resorption anormalement lente fut observee chez tous les huit sujets atteints de lupus erythemateux et il y eut un fort dMlai chez deux d'entre eux.
Les malades atteints d'amyloidose accuserent une vitesse de discoloration faible en l'absence de toute anomalie histologique de la peau.
Un ictere ralentissait l'absorption chez un grand nombre de sujets; ceci etait particulierement prononce dans l'ictere par obstruction.
On ne put trouver aucun facteur commun qui expliquerait comment se produisent ces resultats anormaux.
Resorpci6n del rojo Congo inyectado por via intradermica SUMARIO Se estudi6 en 162 sujetos reumanticos y non-reumaticos la coloraci6n vital de la piel despues de inyecciones intradermicas de una soluci6n de rojo Congo. No se vi6 diferencia alguna entre las velocidades de descolorimiento en los sujetos adultos con artritis reumatoide y los testigos non-reumaticos.
La actividad de la enfermedad reumatica no ejerci6 influencia alguna sobre la velocidad de descolorimiento y no se encontr6 una correlaci6n con la edad en ningun grupo.
Se observe una resorpci6n anormalmente lenta en los ocho casos de lupus eritematoso y en dos de ellos la demora fue considerable.
Los enfermos con amiloidosis acusaron una velocidad de descolorimiento debil en la ausencia de toda anomalia histol6gica de la piel.
La ictericia demoraba la absorpci6n en una gran proporci6n de los casos, particularmente al tratarse de ictericia por obstrucci6n.
No se encontr6 ningun factor comun que pudiera explicar estos resultados anormales.
